How do you feel about the veterinary profession? Wait, here’s a better question: How old are you? How you feel about the profession varies with age, according to a new, first-of-its-kind study conducted by Merck Animal Health and the American Veterinary Medical Association (AVMA).
Catch up on the latest pet and veterinary news from the last week. In this update: Reporting animal abuse becomes mandatory in parts of Canada, a cloned dog gets cloned, and yes, dogs are smarter than cats.
As 2019 draws to a close and we look back over the year that was, NEWStat put together a list of the most popular news stories we published over the last 12 months.
This week: The Empire State considers pot for pets, comfort dogs get their day court, and why you otter-not flush kitty litter.
This week: A frostbitten cat gets 3D-printed paws, a con man peddling canine-cancer cures gets caught, and a veterinary school that admits rejected candidates . . . for a price.
After spending so much time at home with their humans, many pups are in for a surprise when their owners go back to work. Here are some tips on separation anxiety diagnosis, client communication, treatment, management, and more from Valarie V. Tynes, DVM, DACVB, DACAW.
As we kick off a new year, let’s take a look back at our top stories from 2021.
Ready to improve your practice’s diabetes management game? AAHA’s newly revised Diabetes Management Guidelines feature a robust resource center full of mobile-friendly tools and educational materials to empower practitioners and pet owners alike.
This week: checking for microchips becomes law in New York, why more dogs aren't sniffing out cancer, and nipping compassion fatigue in the bud
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.